Results 251 to 260 of about 18,395 (294)

INPP5D/SHIP1-mediated immunometabolic remodeling of renal monocytes in idiopathic membranous nephropathy. [PDF]

Front Immunol
Dai H, Liu B, Rui H, Yang L, Jiang H, Zhao Q, Liu W.   +6 more
europepmc   +1 more source

Morphological and Biochemical Insights Into the Renoprotective Effects of Combined N‐Acetylcysteine and Glycine Treatment in Experimental Diabetic Nephropathy

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT Diabetic nephropathy (DN) is a major microvascular complication of diabetes mellitus and the leading cause of end‐stage renal disease. Oxidative stress and inflammation are central drivers of DN progression, yet no effective therapies exist to prevent or delay renal injury. This study investigated the renoprotective effects of glycine (GLY), N‐
Malik Ejubović, Andrej Belančić, Yun Wah Lam, Farideh Javid, Dina Kapić, Esad Ćosović, Rijad Jahić, Orhan Lepara, Amira Jagodić Ejubović, Lejla Alić, Amil Topuz, Zurifa Ajanović, Almir Fajkić   +12 more
wiley   +1 more source

Circulating Testican-2 and MGT5A are Markers of Membranous Nephropathy. [PDF]

Kidney Int Rep
Kim T, Ju W, Surapaneni A, Li Y, Wen D, Trivin-Avillach C, Rosales IA, Beck LH, Nair V, Fermin D, Zee J, Schmidt IM, Srivastava A, Palsson R, Stillman IE, Kretzler M, NEPTUNE Investigators, Coresh J, Waikar SS, Grams ME, Rhee EP.   +20 more
europepmc   +1 more source

Advances in Erectile Dysfunction Management: What Does Work

Trends in Urology &Men's Health, Volume 17, Issue 3, June 2026.
ABSTRACT Erectile dysfunction (ED) is a prevalent and multifactorial disorder that substantially affects quality of life. Pathophysiology includes vascular, neurogenic, drug‐induced, and psychogenic causes, and frequently coexists with cardiometabolic disease.
Jolie Shen, Daye Park, Jasper Bash, Juan Andino   +3 more
wiley   +1 more source

Response to the Letter to the Editor Entitled "Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy". [PDF]

Kidney Int Rep
Su X, Wu B, Wang L.
europepmc   +1 more source

Tubular Omega‐3 Fatty Acid Receptor FFAR4 Deficiency Aggravated Renal Aging and Chronic Kidney Disease

Aging Cell, Volume 25, Issue 6, June 2026.
This study illustrates that omega‐3 PUFAs with their receptor FFAR4 alleviate tubular senescence and fibrosis in aged and fibrotic kidneys. Furthermore, we indicate that tubular FFAR4 improves renal senescence via 15d‐PGJ2‐PPARγ‐Klotho signaling, and suppresses kidney fibrosis by senescent tubular cell‐driven fibroblast activation.
Letian Yang, Lei Tang, Jian Li, Dekai Liu, Chunchun Hu, Fan Guo, Lin Lin, Rongshuang Huang, Ping Fu, Liang Ma   +9 more
wiley   +1 more source

Membranous nephropathy and hepatitis secondary to syphilis: a case report and literature review. [PDF]

CEN Case Rep
Ashizawa K, Uramatsu T, Tsuyuki T, Ikemi E, Sakamoto R, Tsuji K, Morisaki T, Matsuoka Y, Nakashima M, Katafuchi E, Nakayama T, Ashizawa K, Torigoe K, Kitamura M, Muta K, Nishino T.   +15 more
europepmc   +1 more source

Magnesium as a Bioenergetic Checkpoint Linking Mitochondrial Function, Metabolic Disease, and Aging

Aging Cell, Volume 25, Issue 6, June 2026.
This review positions magnesium as a central bioenergetic checkpoint that orchestrates mitochondrial function and metabolic resilience. By defining the functional ATP pool and stabilizing mitochondrial performance, magnesium homeostasis serves as a mechanistic link between renal handling, metabolic disease, and the aging process.
Chien‐Wei Huang, Chen‐Yueh Wen, Andy P. Tsai, Boyang Wang, Kuan‐Hao Tsui, Yu‐Juei Hsu, Chia‐Jung Li   +6 more
wiley   +1 more source

FSTIV score is essential for clinical management and predicts outcome of idiopathic membranous nephropathy. [PDF]

BMC Nephrol
Liu Y, Wang M, Yang L, Ma J, Zhang G, Bao L, Ma L, Xia W, Zheng Y.   +8 more
europepmc   +1 more source

Efficacy and safety of zuberitamab in the treatment of primary membranous nephropathy: an observational study. [PDF]

Front Immunol
Zong L, Wang S, Zhao K, Lv FY, Qian SK, Yang XD.   +5 more
europepmc   +1 more source